Trials / Completed
CompletedNCT00700661
A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Study to Determine the Efficacy of Montelukast in the Treatment of Exacerbations in Asthmatic Patients Aged 2-to-5 Years
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 2 Years – 5 Years
- Healthy volunteers
- Not accepted
Summary
A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast | One montelukast 4-mg chewable tablet (CT) administered once daily at bedtime. Duration of Treatment: 48 Weeks |
| DRUG | placebo (unspecified) | Matching-image Montelukast placebo. Duration of Treatment: 48 Weeks |
Timeline
- Start date
- 2001-01-01
- Primary completion
- 2002-12-01
- Completion
- 2002-12-01
- First posted
- 2008-06-19
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00700661. Inclusion in this directory is not an endorsement.